FOR IMMEDIATE RELEASE
ATS Research Program Announces 2025 Unrestricted Research Grant Recipients
The award recipients represent institutions from regions across the U.S.
June 23, 2005 --The American Thoracic Society Research Program has announced that five researchers have been selected to receive unrestricted research grants totaling $200,000.
These awards support early-career investigators researching basic science, patient-oriented, or public health topics in pulmonary, critical care, and sleep medicine.
2025 ATS Unrestricted Research Grants
The following researchers will receive one-year grants of $40,000 each:
- Chaofan Li, PhD, University of Virginia: “Molecular Regulation of Respiratory Immune Response Driving Lung Sequelae Post COVID-19.”
- Monica Liu, MD, PhD, University of Wisconsin-Madison: “Validating Patient-Derived Organoid Models of Acute Lung Transplant Rejection.”
- Luciana Padua Tavares, PhD, Brigham and Women's Hospital – Harvard Medical School: “15-Lipoxygenase-Expressing Neutrophils Reprogram Macrophages to Promote Resolution Of ARDS.”
- Richard Ramonell, MD, University of Pittsburgh: “Pathogenic Potential of CD8+ Effector Memory T Cells Re-Expressing CD45RA in Severe Asthma.”
- B. Shoshana Zha, MD, PhD, The Regents of the University of California, San Francisco: “MAC-BeNTM: Macrophage Response in Bronchiectasis and Pulmonary NTM Disease.”
“The American Thoracic Society is proud to support these outstanding early-stage investigators,” said Kamran Atabai, MD, chair of the ATS Scientific Grant Review Committee. “These awards not only reflect the potential impact of this work, but they also provide a crucial stepping stone for early-career researchers to secure larger-scale funding from major institutions.”
The Research Program has aligned its grant cycle with the calendar year and is accepting applications for partner grants until July 1, 2025.
The next grant cycle will open in January 2026. Visit our website for more information.
Fund future respiratory health breakthroughs by donating to the ATS Research Program.
About the ATS Research Program
Since 2004, the ATS Research Program's investment of more than $25M in more than 400 early career researchers has leveraged millions in NIH funding and breakthroughs in respiratory medicine. Investing in early career investigators is crucial for driving advancements in research and transforming patient care. The ATS also emphasizes the importance of cultivating partnerships in business, government, and academia to further support these developments.
About the American Thoracic Society
Founded in 1905, the American Thoracic Society is the world's leading medical society dedicated to accelerating the advancement of global respiratory health through multidisciplinary collaboration, education, and advocacy. Core activities of the Society’s more than 16,000 members are focused on leading scientific discoveries, advancing professional development, impacting global health, and transforming patient care. Key areas of member focus include developing clinical practice guidelines, hosting the annual International Conference, publishing four peer-reviewed journals, advocating for improved respiratory health globally, and developing an array of patient education and career development resources.
Visit our website to learn more.